Loading clinical trials...
Loading clinical trials...
VALO-2 is a multicenter, open-label extension (OLE) study enrolling patients with genotyped keratin mutations KRT6A, KRT6B and KRT16 who were previously treated with investigational PTX-022 during the...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Palvella Therapeutics, Inc.
NCT05643872 · Pachyonychia Congenita
NCT02321423 · Pachyonychia Congenita
NCT05956314 · Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita
NCT05435638 · Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita
NCT01382511 · Pachyonychia Congenita
Arizona Research Center
Phoenix, Arizona
Stanford University
Palo Alto, California
Minnesota Clinical Study Center
Fridley, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions